Literature DB >> 17537556

Prospective study of the incidence of serious posterior maxillary haemorrhage during a tuberosity osteotomy in low level Le Fort I operations.

Barry O'Regan1, Girish Bharadwaj.   

Abstract

The incidence of serious haemorrhage in Le Fort I osteotomy is low and attempts to reduce this further have led to the development of various techniques to minimise vascular injury. This includes the tuberosity osteotomy and was published over two decades ago. This technique has not been widely adopted as shown by a recent UK survey of consultants, which suggested that only 12 (7%) of the 175 surgeons who responded, routinely use tuberosity osteotomy in non-cleft low level Le Fort I procedures. The aim of the study was to examine prospectively the incidence of serious haemorrhage from the posterior maxilla during tuberosity osteotomy. We report 35 consecutive patients who have had no operative or postoperative vascular complications.

Entities:  

Mesh:

Year:  2007        PMID: 17537556     DOI: 10.1016/j.bjoms.2007.03.006

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  10 in total

1.  Comparison of precision and accuracy of linear measurements performed by two different imaging software programs and obtained from 3D-CBCT images for Le Fort I osteotomy.

Authors:  B F Gaia; L R Pinheiro; O S Umetsubo; F F Costa; M G P Cavalcanti
Journal:  Dentomaxillofac Radiol       Date:  2013-03-21       Impact factor: 2.419

2.  Aberrations in Maxillary Anatomy of Adult Patients with Cleft Maxillary Hypoplasia: A Computed Tomographic Study.

Authors:  Sreeya Shankari Kandaswamy; Shanmugasundaram Somasundaram; Sneha Pendem; V B Krishna Kumar Raja
Journal:  J Maxillofac Oral Surg       Date:  2020-07-08

3.  Linear and angular measurement using cone-beam computed tomography to enhance safety in Le Fort I osteotomy with tuberosity cut.

Authors:  Liuling Hui; Kuo Feng Hung; Michael Marc Bornstein; Yiu Yan Leung
Journal:  Clin Oral Investig       Date:  2022-08-15       Impact factor: 3.606

4.  Evaluation of Post-operative Complication Rate of Le Fort I Osteotomy: A Retrospective and Prospective Study.

Authors:  Sandeep Garg; Supreet Kaur
Journal:  J Maxillofac Oral Surg       Date:  2012-12-14

Review 5.  Preoperative, intraoperative, and postoperative complications in orthognathic surgery: a systematic review.

Authors:  M Jędrzejewski; T Smektała; K Sporniak-Tutak; R Olszewski
Journal:  Clin Oral Investig       Date:  2015-03-26       Impact factor: 3.573

6.  Prognostic factors for maxillary sinus mucosal thickening following Le Fort I osteotomy: a retrospective analysis.

Authors:  Masashi Iwamoto; Miki Watanabe; Masae Yamamoto; Masato Narita; Takashi Kamio; Takashi Takaki; Takahiko Shibahara; Akira Katakura
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-03-11

7.  Delayed Epistaxis which Was Developed after Orthognathic Surgery with Le Fort I Osteotomy and Managed by Endoscopic Cauterization.

Authors:  Yuya Kurasawa; Hitoshi Sato; Ryogo Katada; Takanobu Inada; Tatsuo Shirota; Toshikazu Shimane
Journal:  Case Rep Dent       Date:  2022-02-22

8.  Delayed progressive haematoma after Le Fort I osteotomy: A possible severe complication in orthognatic surgery.

Authors:  Dario Bertossi; Luciano Malchiodi; Ehsani Shideh; Massimo Albanese; Marco Portelli; Alessandra Lucchese; Francesco Carinci; Pierfrancesco Nocini
Journal:  Dent Res J (Isfahan)       Date:  2012-12

9.  The pterygomaxillary junction: An imaging study for surgical information of LeFort I osteotomy.

Authors:  Yen-Po Chin; Maria Belen Leno; Sarayuth Dumrongwongsiri; Kyung Hoon Chung; Hsiu-Hsia Lin; Lun-Jou Lo
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

10.  Complications or rather side effects? Quantification of patient satisfaction and complications after orthognathic surgery-a retrospective, cross-sectional long-term analysis.

Authors:  Daniel G E Thiem; Daniel Schneider; Michael Hammel; Bassam Saka; Bernhard Frerich; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Clin Oral Investig       Date:  2020-11-06       Impact factor: 3.573

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.